A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
Main Authors: | Bhaskar, Vinay, Goldfine, Ira D., Bedinger, Daniel H., Lau, Angela, Kuan, Hua F., Gross, Lisa M., Handa, Masahisa, Maddux, Betty A., Watson, Susan R., Zhu, Shirley, Narasimha, Ajay J., Levy, Raphael, Webster, Lynn, Wijesuriya, Sujeewa D., Liu, Naichi, Wu, Xiaorong, Chemla-Vogel, David, Tran, Catarina, Lee, Steve R., Wong, Steve, Wilcock, Diane, White, Mark L., Corbin, John A. |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331746/ |
Similar Items
-
Improved Glucose Metabolism In Vitro and In Vivo by an Allosteric Monoclonal Antibody That Increases Insulin Receptor Binding Affinity
by: Corbin, John A., et al.
Published: (2014) -
Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: A potential new approach for the treatment of hyperinsulinemic hypoglycemia
by: Corbin, John A, et al.
Published: (2014) -
Insulin Resistance Induced by Hyperinsulinemia Coincides with a Persistent Alteration at the Insulin Receptor Tyrosine Kinase Domain
by: Catalano, Karyn J., et al.
Published: (2014) -
Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity
by: Masharani, Umesh, et al.
Published: (2012) -
Commissioning Dementia Care: Implementing the National Dementia Strategy
by: Steve, Iliffe, et al.
Published: (2009)